183 related articles for article (PubMed ID: 7541600)
1. Principal components and further possibilities with the PANSS.
von Knorring L; Lindström E
Acta Psychiatr Scand Suppl; 1995; 388():5-10. PubMed ID: 7541600
[TBL] [Abstract][Full Text] [Related]
2. New pharmacotherapeutic modalities for negative symptoms in psychosis.
Lindenmayer JP
Acta Psychiatr Scand Suppl; 1995; 388():15-9. PubMed ID: 7541598
[TBL] [Abstract][Full Text] [Related]
3. The Swedish version of the Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Construct validity and interrater reliability.
von Knorring L; Lindström E
Acta Psychiatr Scand; 1992 Dec; 86(6):463-8. PubMed ID: 1281960
[TBL] [Abstract][Full Text] [Related]
4. Five-component model of schizophrenia: assessing the factorial invariance of the positive and negative syndrome scale.
Bell MD; Lysaker PH; Beam-Goulet JL; Milstein RM; Lindenmayer JP
Psychiatry Res; 1994 Jun; 52(3):295-303. PubMed ID: 7991723
[TBL] [Abstract][Full Text] [Related]
5. Interrater reliability of the Structured Clinical Interview for the Positive and Negative Syndrome Scale for schizophrenia.
Lindström E; Wieselgren IM; von Knorring L
Acta Psychiatr Scand; 1994 Mar; 89(3):192-5. PubMed ID: 8178678
[TBL] [Abstract][Full Text] [Related]
6. The negative component in schizophrenia.
Möller HJ
Acta Psychiatr Scand Suppl; 1995; 388():11-4. PubMed ID: 7541597
[TBL] [Abstract][Full Text] [Related]
7. Psychopathological dimensions in schizophrenia.
Cuesta MJ; Peralta V
Schizophr Bull; 1995; 21(3):473-82. PubMed ID: 7481577
[TBL] [Abstract][Full Text] [Related]
8. Internal consistency, temporal stability and neuropsychological correlates of three cognitive components of the Positive and Negative Syndrome Scale (PANSS).
Bryson G; Bell M; Greig T; Kaplan E
Schizophr Res; 1999 Jul; 38(1):27-35. PubMed ID: 10427608
[TBL] [Abstract][Full Text] [Related]
9. Long-term treatment of mood disorders in schizophrenia.
Azorin JM
Acta Psychiatr Scand Suppl; 1995; 388():20-3. PubMed ID: 7541599
[TBL] [Abstract][Full Text] [Related]
10. [A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS].
Loas G; Noisette C; Legrand A; Delahousse J
Encephale; 1997; 23(1):10-8. PubMed ID: 9172962
[TBL] [Abstract][Full Text] [Related]
11. Anhedonia and negative symptomatology in chronic schizophrenia.
Loas G; Boyer P; Legrand A
Compr Psychiatry; 1996; 37(1):5-11. PubMed ID: 8770519
[TBL] [Abstract][Full Text] [Related]
12. Risperidone, negative symptoms and cognitive deficit in schizophrenia: an open study.
Rossi A; Mancini F; Stratta P; Mattei P; Gismondi R; Pozzi F; Casacchia M
Acta Psychiatr Scand; 1997 Jan; 95(1):40-3. PubMed ID: 9051159
[TBL] [Abstract][Full Text] [Related]
13. An excitement subscale of the Positive and Negative Syndrome Scale.
Lindenmayer JP; Brown E; Baker RW; Schuh LM; Shao L; Tohen M; Ahmed S; Stauffer VL
Schizophr Res; 2004 Jun; 68(2-3):331-7. PubMed ID: 15099614
[TBL] [Abstract][Full Text] [Related]
14. Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia.
Peralta V; Cuesta MJ
Psychiatry Res; 1994 Jul; 53(1):31-40. PubMed ID: 7991730
[TBL] [Abstract][Full Text] [Related]
15. [The PANSS (Positive And Negative Symptom) Scale].
Guelfi JD
Encephale; 1997 Apr; 23 Spec No 2():35-8. PubMed ID: 9273305
[TBL] [Abstract][Full Text] [Related]
16. Assessing positive and negative symptoms in children and adolescents.
Fields JH; Grochowski S; Lindenmayer JP; Kay SR; Grosz D; Hyman RB; Alexander G
Am J Psychiatry; 1994 Feb; 151(2):249-53. PubMed ID: 8296898
[TBL] [Abstract][Full Text] [Related]
17. Inter-rater reliability of ratings on the six-item Positive and Negative Syndrome Scale (PANSS-6) obtained using the Simplified Negative and Positive Symptoms Interview (SNAPSI).
Kølbæk P; Blicher AB; Buus CW; Feller SG; Holm T; Dines D; O'Leary KM; Sørensen RS; Opler M; Correll CU; Mors O; Bech P; Østergaard SD
Nord J Psychiatry; 2018 Aug; 72(6):431-436. PubMed ID: 30037286
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
Citrome L; Meng X; Hochfeld M; Stahl SM
Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738
[TBL] [Abstract][Full Text] [Related]
19. Symptom structure and severity: a comparison of responses to the positive and negative syndrome scale (PANSS) between patients with PTSD or schizophrenia.
Stefanovics EA; Krystal JH; Rosenheck RA
Compr Psychiatry; 2014 May; 55(4):887-95. PubMed ID: 24602497
[TBL] [Abstract][Full Text] [Related]
20. Validation of ratings on the six-item Positive and Negative Syndrome Scale obtained via the Simplified Negative and Positive Symptoms Interview among outpatients with schizophrenia.
Nielsen CM; Kølbæk P; Dines D; Pedersen ML; Danielsen AA; Holmgård C; Wissing S; Esbøl AM; Fuglsang NFB; Nguyen TD; Mors O; Opler M; Correll CU; Østergaard SD
J Psychopharmacol; 2022 Nov; 36(11):1208-1217. PubMed ID: 36268705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
